Compagnie Gervais Danone

Harvard College

Biopolis, S.l.

Isabelle Chambaud

Gianfranco Grompone

Sophie Legrain-Raspaud

Marie-Christine Degivry

Biliana Lesic

Artem Khlebnikov

Tamara Smokvina

Sandrine Capronnier

Anne-Catherine Villain

Thierry Saint Denis

Laurie H Glimcher

Daniel Ramon Vidal

Raphaëlle Bourdet-Sicard

Wendy Sarah Garrett

Patricia Martorell Guerola

Salvador Genoves Martinez

Michel Neunlist

Anne Druesne

Nuria Gonzalez Martinez

Patrick Veiga

Legrain-Raspaud Sophie

The present invention concerns strains ofcapable of inhibiting the growth of a pathogenic microorganism and/or improving the intestinal epithelial barrier integrity. These strains are suitable for use in the treatment or prevention of a digestive disorder.

[object Object]

The invention relates to the use of lactic acid bacteria, for use in improving transepithelial resistance and more particularly in treating and/or preventing constipation and/or irritable bowel disease.

Probiotic strains for use in improving transepithelial resistance

The invention relates to the use of lactic acid bacteria, for use in modifying the enteric nervous system and more particularly in treating and/or preventing intestinal disorders such as constipation and/or irritable bowel disease.

Probiotic strains for use in improving the enteric nervous system

The present invention relates to specificstrains with an anti-oxidant effect.

The present invention relates to a method usingfor screening of food grade bacteria which have a protective effect against oxidative stress.

Method for selecting bacteria with anti-oxidant action

The invention relates to a novel strain of, having antimicrobial and immunomodulatory properties, and to compositions containing said strain.

The present invention relates to a method for the prevention, treatment and reduction of gastro-intestinal inflammation in a subject by administering a specificbacteria, in particular a fermented dairy product comprising said specificbacteria for the prevention, treatment and reduction of gastro-intestinal inflammation, in particular for the prevention and treatment of inflammatory bowel disease (IBD), ulcerative colitis (UC) and/or Crohn's Disease (CD) and for the prevention and treatment of Irritable Bowel Syndrome (IBS).

The invention relates to a novel strain ofsubspecies, having antimicrobial and immunomodulatory properties, and to compositions containing said strain.

Growing community of inventors

Issy les Moulineaux, France

Isabelle Chambaud